A shorter course of AZT therapy than currently prescribed for HIV-infected pregnant women may allow women in developing countries to afford the treatment that can reduce their babies' chances of contracting AIDS--at a much lower cost, according to a study in the October 5 New England Journal of Medicine. As a supplement to this story Vidyya has the prescribing information for AZT, now known by the name Retrovir by its manufacturer, for your use.
In other HIV news, Bruce Walker, an immunology researcher and AIDS treatment specialist from Massachusetts General found himself on the cover of the Wall Street Journal this week when the journal reported the results of his 8-patient study. The study has big research ramifications. Dr. Walker's group treated a group of very recently infected HIV patients with drugs. The drugs were stopped when the virus was held in check, and the immune system of the patients developed a vigorous response. In most of the eight patients, the virus remained under control-without benefit of medication.
October is Breast Cancer Awareness Month (BCAM). As a part of BCAM, National Mammography Day is held on the third Friday in October each year. On this day, or throughout the month, radiologists provide discounted or free screening mammograms. In 1999, more than 2,200 American College of Radiology (ACR) accredited facilities took part. To help provide you with additional information regarding mammography screening in the community, Vidyya is pleased to offer this report, Reaching Women for Mammography Screening: Successful Strategies of National Breast and Cervical Cancer Early Detection Program from the Centers for Disease Control (CDC).
In other breast cancer news, in one of the largest studies on the long-term health effects of silicone breast implants, researchers from the National Cancer Institute (NCI) in Bethesda, Md., found no association between breast implants and the subsequent risk of breast cancer. The study is published in the November issue of Cancer Causes and Control.
The articles in today's Vidyya are:
As always, we hope you enjoy the issue.